Economic Calendar & Watch List 9/8/2105


Tuesday September 8, 2015


Economic Calendar & Watch List 9/8/2015


Morning Notes

US futures are significantly higher this morning by nearly 2% and European markets are trading higher by over 2% after a sharp rally in Chinese markets.




The SPY gapped down and closed lower on Friday after the August Jobs report which created new levels of support and resistance. Support will lie at $191.61, followed by $190.73. Resistance lies at $193.86, $194.96, and $198.05.


In Play

IMMU: Immunomedics – The company said the sacituzumab drug continues to produce “Durable responses in patients with metastatic lung cancer who had relapsed or were refractory to their last cancer therapy.” Gapping up 30% with a 87M share float.

NSPH: Nanosphere – The company announced it has received FDA Clearance for Flexible Pathogens Test. NSPH also was rated new buy at Chardan Capital Markets. Gapping up 27% with a 6.7M share float.

ICLD: InterCloud Systems – The company announced today that it has been selected by one of the world’s largest global systems integrators as a prime vendor to deliver outsourced managed services and support for one of the largest US government agency’s next generation voice and data network. The contract term is for five years and is projected to be worth at least $10 million during the base term. The contract award is effective immediately and transition of services is currently underway. Gapping up 11% with a 21M share float.


**Others On Watch**




Economic Calendar

11:00 USDA weekly grain export inspections

1:00 Treasury auctions $24 billion of 3-year T-notes

3:00 Jul consumer credit expected +$18.55 billion

4:00 USDA weekly crop progress

5:15 Minneapolis Fed President Kocherlakota speaks on the outlook for U.S. monetary policy


Earnings Before Open

YGE: Yingli Green Energy – Eps Est. $(.22)


Earnings After Close

PLAY: Dave & Buster’s – Eps Est. $.23, Rev Est. $204.3M

MW: Men’s Wearhouse – Eps Est. $1.05, Rev Est. $946.76M
FCEL: FuelCell – Eps Est. $(.02), Rev Est. $43M